PI
-
Subcutaneous administration of natalizumab can lead to lower drug concentrations compared to intravenous administration
Gelissen, L. M. Y., Loveless, S., Toorop, A. A., Howlett, J., Loeff, F. C., Rispens, T., Killestein, J., Tallantyre, E. C. & van Kempen, Z. L. E., 1 Oct 2024, In: Multiple Sclerosis and Related Disorders. 90, 105796.Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
Clinical risk stratification: Development and validation of the DAAE score, a tool for estimating patient risk of transition to secondary progressive multiple sclerosis
Fuchs, T. A., Zivadinov, R., Pryshchepova, T., Weinstock-Guttman, B., Dwyer, M. G., Benedict, R. H. B., Bergsland, N., Jakimovski, D., Uher, T., Jelgerhuis, J. R., Barkhof, F., Uitdehaag, B. M. J., Killestein, J., Strijbis, E. M. M. & Schoonheim, M. M., 1 Sept 2024, In: Multiple Sclerosis and Related Disorders. 89, 105755.Research output: Contribution to journal › Article › Academic › peer-review
-
Digital outcome measures are associated with brain atrophy in patients with multiple sclerosis
Molenaar, P. C. G., Noteboom, S., van Nederpelt, D. R., Krijnen, E. A., Jelgerhuis, J. R., Lam, K-H., Druijff-van de Woestijne, G. B., Meijer, K. A., van Oirschot, P., de Jong, B. A., Brouwer, I., Jasperse, B., de Groot, V., Uitdehaag, B. M. J., Schoonheim, M. M., Strijbis, E. M. M. & Killestein, J., 15 Jul 2024, (E-pub ahead of print) In: Journal of neurology.Research output: Contribution to journal › Article › Academic › peer-review
- All publications